ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01066390
Recruitment Status : Completed
First Posted : February 10, 2010
Last Update Posted : May 6, 2014
Sponsor:
Information provided by (Responsible Party):
Bart Neyns, Universitair Ziekenhuis Brussel

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2013
  Actual Study Completion Date : May 2014